{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "5bc8c19e",
   "metadata": {},
   "outputs": [],
   "source": [
    "from transformers import AutoTokenizer, BitsAndBytesConfig, AutoModelForCausalLM\n",
    "from peft import PeftConfig, AutoPeftModelForCausalLM, PeftModel\n",
    "import torch\n",
    "import os\n",
    "\n",
    "import pandas as pd\n",
    "from datasets import load_dataset\n",
    "from tqdm.auto import tqdm"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "70b91371",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Loading checkpoint shards: 100%|██████████| 4/4 [00:28<00:00,  7.18s/it]\n",
      "/root/miniconda3/envs/LLM/lib/python3.12/site-packages/peft/config.py:165: UserWarning: Unexpected keyword arguments ['alora_invocation_tokens', 'arrow_config', 'ensure_weight_tying', 'peft_version'] for class LoraConfig, these are ignored. This probably means that you're loading a configuration file that was saved using a higher version of the library and additional parameters have been introduced since. It is highly recommended to upgrade the PEFT version before continuing (e.g. by running `pip install -U peft`).\n",
      "  warnings.warn(\n"
     ]
    }
   ],
   "source": [
    "bnb_config = BitsAndBytesConfig(\n",
    "    load_in_4bit = True,\n",
    "    bnb_4bit_use_double_quant = True,\n",
    "    bnb_4bit_quant_type = \"nf4\",\n",
    "    bnb_4bit_compute_dtype = torch.bfloat16\n",
    ")\n",
    "\n",
    "adapter_name = \"../adapter/Zip-Llama-aligned\"\n",
    "\n",
    "model = AutoModelForCausalLM.from_pretrained(\n",
    "    \"meta-llama/Llama-3.1-8B-Instruct\",\n",
    "    quantization_config = bnb_config,\n",
    "    attn_implementation = \"eager\",\n",
    "    use_cache = True,\n",
    "    dtype = torch.bfloat16,\n",
    "    device_map = \"cuda:0\"\n",
    ")\n",
    "\n",
    "model = PeftModel.from_pretrained(model, os.path.join(adapter_name, \"policy\"))\n",
    "tokenizer = AutoTokenizer.from_pretrained(adapter_name, use_fast = True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "edcaaa72",
   "metadata": {},
   "outputs": [],
   "source": [
    "tokenizer.pad_token = tokenizer.eos_token\n",
    "tokenizer.pad_token_id = tokenizer.eos_token_id\n",
    "tokenizer.padding_side = \"left\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "38018556",
   "metadata": {},
   "outputs": [],
   "source": [
    "vllm_inf = pd.read_csv(\"../data/inference_result_greedy.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "19fe744e",
   "metadata": {},
   "outputs": [],
   "source": [
    "gen_ds = load_dataset(\"json\", data_files = \"../data/inference_data.json\", split = \"train\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "de1d7463",
   "metadata": {},
   "outputs": [],
   "source": [
    "idx = 0\n",
    "\n",
    "input_ids = tokenizer.apply_chat_template(\n",
    "                gen_ds[idx][\"messages\"],\n",
    "                add_generation_prompt=True,\n",
    "                return_tensors=\"pt\"\n",
    ").to(model.device)\n",
    "\n",
    "terminators = [tokenizer.eos_token_id]\n",
    "\n",
    "outputs = model.generate(\n",
    "    input_ids,\n",
    "    max_new_tokens=512,\n",
    "    eos_token_id=terminators,\n",
    "    pad_token_id=tokenizer.eos_token_id,\n",
    "    do_sample=False,\n",
    "    num_beams=1\n",
    ")\n",
    "\n",
    "response = outputs[0][input_ids.shape[-1]:]\n",
    "generation = tokenizer.decode(response, skip_special_tokens=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "fe27e9c5",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "A female patient presented with foot ulcer and hammer toes; on physical examination, BP NA, HR NA, RR NA, and Temp NA; admission labs showed WBC 5.6, RBC 4.15, Hgb 11.1, Hct 32.9, Plt NA, MCV 79, MCH 26.6, MCHC 33.6, RDW 13.7, and Glucose 114; the most diagnostically relevant finding was a right submetatarsal ulcer with partial-thickness skin loss and exposed bone.\n"
     ]
    }
   ],
   "source": [
    "print(generation)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "808551a0",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "A female patient presented with foot ulcer and hammer toes; on physical examination, BP NA, HR NA, RR NA and Temp NA; admission labs showed WBC 5.6, RBC 4.15, Hgb 11.1, Hct 32.9, Plt NA, MCV 79, MCH 26.6, MCHC 33.6, RDW 13.7, and Glucose 114; the most diagnostically relevant finding was a right submetatarsal ulcer with hammer digit syndrome affecting 4 toes.\n"
     ]
    }
   ],
   "source": [
    "print(vllm_inf.iloc[0, 1])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "4058cd94",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "A female patient presented with foot ulcer and hammer toes; on physical examination, BP NA, HR NA, RR NA, and Temp NA; admission labs showed WBC 5.6, RBC 4.15, Hgb 11.1, Hct 32.9, Plt NA, MCV 79, MCH 26.6, MCHC 33.6, RDW 13.7, and Glucose 114; the most diagnostically relevant finding was a right submetatarsal ulcer with hammer digit syndrome.\n"
     ]
    }
   ],
   "source": [
    "print(generation)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "06403395",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "A female patient presented with foot ulcer and hammer toes; on physical examination, BP NA, HR NA, RR NA, and Temp NA; admission labs showed WBC 5.6, RBC 4.15, Hgb 11.1, Hct 32.9, Plt NA, MCV 79, MCH 26.6, MCHC 33.6, RDW 13.7, and Glucose 114; the most diagnostically relevant finding was a right submetatarsal ulcer with partial-thickness skin loss and exposed bone.\n"
     ]
    }
   ],
   "source": [
    "print(generation)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "3d7e198c",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/root/miniconda3/envs/LLM/lib/python3.12/site-packages/tqdm/auto.py:21: TqdmWarning: IProgress not found. Please update jupyter and ipywidgets. See https://ipywidgets.readthedocs.io/en/stable/user_install.html\n",
      "  from .autonotebook import tqdm as notebook_tqdm\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "INFO 11-20 10:59:16 [utils.py:253] non-default args: {'trust_remote_code': True, 'dtype': torch.bfloat16, 'max_model_len': 32768, 'gpu_memory_utilization': 0.3, 'disable_log_stats': True, 'enable_lora': True, 'max_lora_rank': 64, 'model': 'base_model/Llama-3.1-8B-Instruct-nf4'}\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "The argument `trust_remote_code` is to be used with Auto classes. It has no effect here and is ignored.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "INFO 11-20 10:59:16 [model.py:631] Resolved architecture: LlamaForCausalLM\n",
      "INFO 11-20 10:59:16 [model.py:1745] Using max model len 32768\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-11-20 10:59:17,106\tINFO util.py:154 -- Missing packages: ['ipywidgets']. Run `pip install -U ipywidgets`, then restart the notebook server for rich notebook output.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "INFO 11-20 10:59:17 [scheduler.py:216] Chunked prefill is enabled with max_num_batched_tokens=16384.\n",
      "\u001b[1;36m(EngineCore_DP0 pid=3440340)\u001b[0;0m INFO 11-20 10:59:17 [core.py:93] Initializing a V1 LLM engine (v0.11.1) with config: model='base_model/Llama-3.1-8B-Instruct-nf4', speculative_config=None, tokenizer='base_model/Llama-3.1-8B-Instruct-nf4', skip_tokenizer_init=False, tokenizer_mode=auto, revision=None, tokenizer_revision=None, trust_remote_code=True, dtype=torch.bfloat16, max_seq_len=32768, download_dir=None, load_format=bitsandbytes, tensor_parallel_size=1, pipeline_parallel_size=1, data_parallel_size=1, disable_custom_all_reduce=False, quantization=bitsandbytes, enforce_eager=False, kv_cache_dtype=auto, device_config=cuda, structured_outputs_config=StructuredOutputsConfig(backend='auto', disable_fallback=False, disable_any_whitespace=False, disable_additional_properties=False, reasoning_parser='', reasoning_parser_plugin='', enable_in_reasoning=False), observability_config=ObservabilityConfig(show_hidden_metrics_for_version=None, otlp_traces_endpoint=None, collect_detailed_traces=None), seed=0, served_model_name=base_model/Llama-3.1-8B-Instruct-nf4, enable_prefix_caching=True, enable_chunked_prefill=True, pooler_config=None, compilation_config={'level': None, 'mode': <CompilationMode.VLLM_COMPILE: 3>, 'debug_dump_path': None, 'cache_dir': '', 'compile_cache_save_format': 'binary', 'backend': 'inductor', 'custom_ops': ['none'], 'splitting_ops': ['vllm::unified_attention', 'vllm::unified_attention_with_output', 'vllm::unified_mla_attention', 'vllm::unified_mla_attention_with_output', 'vllm::mamba_mixer2', 'vllm::mamba_mixer', 'vllm::short_conv', 'vllm::linear_attention', 'vllm::plamo2_mamba_mixer', 'vllm::gdn_attention_core', 'vllm::kda_attention', 'vllm::sparse_attn_indexer'], 'compile_mm_encoder': False, 'use_inductor': None, 'compile_sizes': [], 'inductor_compile_config': {'enable_auto_functionalized_v2': False, 'combo_kernels': True, 'benchmark_combo_kernel': True}, 'inductor_passes': {}, 'cudagraph_mode': <CUDAGraphMode.FULL_AND_PIECEWISE: (2, 1)>, 'cudagraph_num_of_warmups': 1, 'cudagraph_capture_sizes': [1, 2, 4, 8, 16, 24, 32, 40, 48, 56, 64, 72, 80, 88, 96, 104, 112, 120, 128, 136, 144, 152, 160, 168, 176, 184, 192, 200, 208, 216, 224, 232, 240, 248, 256, 272, 288, 304, 320, 336, 352, 368, 384, 400, 416, 432, 448, 464, 480, 496, 512], 'cudagraph_copy_inputs': False, 'cudagraph_specialize_lora': True, 'use_inductor_graph_partition': False, 'pass_config': {}, 'max_cudagraph_capture_size': 512, 'local_cache_dir': None}\n",
      "\u001b[1;36m(EngineCore_DP0 pid=3440340)\u001b[0;0m INFO 11-20 10:59:18 [parallel_state.py:1208] world_size=1 rank=0 local_rank=0 distributed_init_method=tcp://172.17.0.4:34917 backend=nccl\n",
      "\u001b[1;36m(EngineCore_DP0 pid=3440340)\u001b[0;0m INFO 11-20 10:59:18 [parallel_state.py:1394] rank 0 in world size 1 is assigned as DP rank 0, PP rank 0, TP rank 0, EP rank 0\n",
      "[Gloo] Rank 0 is connected to 0 peer ranks. Expected number of connected peer ranks is : 0\n",
      "[Gloo] Rank 0 is connected to 0 peer ranks. Expected number of connected peer ranks is : 0\n",
      "[Gloo] Rank 0 is connected to 0 peer ranks. Expected number of connected peer ranks is : 0\n",
      "[Gloo] Rank 0 is connected to 0 peer ranks. Expected number of connected peer ranks is : 0\n",
      "[Gloo] Rank 0 is connected to 0 peer ranks. Expected number of connected peer ranks is : 0\n",
      "[Gloo] Rank 0 is connected to 0 peer ranks. Expected number of connected peer ranks is : 0\n",
      "\u001b[1;36m(EngineCore_DP0 pid=3440340)\u001b[0;0m INFO 11-20 10:59:19 [gpu_model_runner.py:3255] Starting to load model base_model/Llama-3.1-8B-Instruct-nf4...\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Traceback (most recent call last):\n",
      "  File \"/root/miniconda3/envs/LLM/lib/python3.12/site-packages/tvm_ffi/utils/_build_optional_torch_c_dlpack.py\", line 836, in <module>\n",
      "    main()\n",
      "  File \"/root/miniconda3/envs/LLM/lib/python3.12/site-packages/tvm_ffi/utils/_build_optional_torch_c_dlpack.py\", line 829, in main\n",
      "    build_ninja(build_dir=str(build_dir))\n",
      "  File \"/root/miniconda3/envs/LLM/lib/python3.12/site-packages/tvm_ffi/cpp/extension.py\", line 353, in build_ninja\n",
      "    raise RuntimeError(\"\\n\".join(msg))\n",
      "RuntimeError: ninja exited with status 1\n",
      "stdout:\n",
      "[1/2] c++ -MMD -MF main.o.d -std=c++17 -fPIC -O3 -DBUILD_WITH_CUDA -D_GLIBCXX_USE_CXX11_ABI=1 -I/root/miniconda3/envs/LLM/lib/python3.12/site-packages/tvm_ffi/include -I/root/miniconda3/envs/LLM/include/python3.12 -I/root/miniconda3/envs/LLM/lib/python3.12/site-packages/torch/include -I/root/miniconda3/envs/LLM/lib/python3.12/site-packages/torch/include/torch/csrc/api/include -I/usr/local/cuda-12.3/include -c /tmp/tvm-ffi-torch-c-dlpack-grmi8l2h/addon.cc -o main.o\n",
      "\u001b[31mFAILED: [code=1] \u001b[0mmain.o \n",
      "c++ -MMD -MF main.o.d -std=c++17 -fPIC -O3 -DBUILD_WITH_CUDA -D_GLIBCXX_USE_CXX11_ABI=1 -I/root/miniconda3/envs/LLM/lib/python3.12/site-packages/tvm_ffi/include -I/root/miniconda3/envs/LLM/include/python3.12 -I/root/miniconda3/envs/LLM/lib/python3.12/site-packages/torch/include -I/root/miniconda3/envs/LLM/lib/python3.12/site-packages/torch/include/torch/csrc/api/include -I/usr/local/cuda-12.3/include -c /tmp/tvm-ffi-torch-c-dlpack-grmi8l2h/addon.cc -o main.o\n",
      "In file included from /tmp/tvm-ffi-torch-c-dlpack-grmi8l2h/addon.cc:8:\n",
      "/root/miniconda3/envs/LLM/lib/python3.12/site-packages/torch/include/c10/cuda/CUDAStream.h:3:10: fatal error: cuda_runtime_api.h: No such file or directory\n",
      "    3 | #include <cuda_runtime_api.h>\n",
      "      |          ^~~~~~~~~~~~~~~~~~~~\n",
      "compilation terminated.\n",
      "ninja: build stopped: subcommand failed.\n",
      "\n",
      "\u001b[1;36m(EngineCore_DP0 pid=3440340)\u001b[0;0m /root/miniconda3/envs/LLM/lib/python3.12/site-packages/tvm_ffi/_optional_torch_c_dlpack.py:106: UserWarning: Failed to JIT torch c dlpack extension, EnvTensorAllocator will not be enabled.\n",
      "\u001b[1;36m(EngineCore_DP0 pid=3440340)\u001b[0;0m You may try AOT-module via `pip install torch-c-dlpack-ext`\n",
      "\u001b[1;36m(EngineCore_DP0 pid=3440340)\u001b[0;0m   warnings.warn(\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[1;36m(EngineCore_DP0 pid=3440340)\u001b[0;0m INFO 11-20 10:59:24 [cuda.py:418] Valid backends: ['FLASH_ATTN', 'FLASHINFER', 'TRITON_ATTN', 'FLEX_ATTENTION']\n",
      "\u001b[1;36m(EngineCore_DP0 pid=3440340)\u001b[0;0m INFO 11-20 10:59:24 [cuda.py:427] Using FLASH_ATTN backend.\n",
      "\u001b[1;36m(EngineCore_DP0 pid=3440340)\u001b[0;0m INFO 11-20 10:59:24 [bitsandbytes_loader.py:791] Loading weights with BitsAndBytes quantization. May take a while ...\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Loading safetensors checkpoint shards:   0% Completed | 0/2 [00:00<?, ?it/s]\n",
      "Loading safetensors checkpoint shards: 100% Completed | 2/2 [00:00<00:00, 25.70it/s]\n",
      "\u001b[1;36m(EngineCore_DP0 pid=3440340)\u001b[0;0m \n",
      "Loading safetensors checkpoint shards:   0% Completed | 0/2 [00:00<?, ?it/s]\n",
      "Loading safetensors checkpoint shards:  50% Completed | 1/2 [00:05<00:05,  5.34s/it]\n",
      "Loading safetensors checkpoint shards: 100% Completed | 2/2 [00:06<00:00,  2.96s/it]\n",
      "Loading safetensors checkpoint shards: 100% Completed | 2/2 [00:06<00:00,  3.32s/it]\n",
      "\u001b[1;36m(EngineCore_DP0 pid=3440340)\u001b[0;0m \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[1;36m(EngineCore_DP0 pid=3440340)\u001b[0;0m INFO 11-20 10:59:31 [punica_selector.py:20] Using PunicaWrapperGPU.\n",
      "\u001b[1;36m(EngineCore_DP0 pid=3440340)\u001b[0;0m INFO 11-20 10:59:31 [gpu_model_runner.py:3334] Model loading took 6.0187 GiB memory and 11.383862 seconds\n",
      "\u001b[1;36m(EngineCore_DP0 pid=3440340)\u001b[0;0m INFO 11-20 10:59:44 [backends.py:631] Using cache directory: /root/.cache/vllm/torch_compile_cache/9b5f756d58/rank_0_0/backbone for vLLM's torch.compile\n",
      "\u001b[1;36m(EngineCore_DP0 pid=3440340)\u001b[0;0m INFO 11-20 10:59:44 [backends.py:647] Dynamo bytecode transform time: 12.31 s\n",
      "\u001b[1;36m(EngineCore_DP0 pid=3440340)\u001b[0;0m INFO 11-20 10:59:48 [backends.py:210] Directly load the compiled graph(s) for dynamic shape from the cache, took 3.238 s\n",
      "\u001b[1;36m(EngineCore_DP0 pid=3440340)\u001b[0;0m INFO 11-20 10:59:51 [monitor.py:34] torch.compile takes 15.55 s in total\n",
      "\u001b[1;36m(EngineCore_DP0 pid=3440340)\u001b[0;0m INFO 11-20 10:59:52 [gpu_worker.py:359] Available KV cache memory: 30.96 GiB\n",
      "\u001b[1;36m(EngineCore_DP0 pid=3440340)\u001b[0;0m INFO 11-20 10:59:52 [kv_cache_utils.py:1229] GPU KV cache size: 253,616 tokens\n",
      "\u001b[1;36m(EngineCore_DP0 pid=3440340)\u001b[0;0m INFO 11-20 10:59:52 [kv_cache_utils.py:1234] Maximum concurrency for 32,768 tokens per request: 7.74x\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Capturing CUDA graphs (mixed prefill-decode, PIECEWISE):   0%|          | 0/102 [00:00<?, ?it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[1;36m(EngineCore_DP0 pid=3440340)\u001b[0;0m WARNING 11-20 10:59:53 [utils.py:250] Using default LoRA kernel configs\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Capturing CUDA graphs (mixed prefill-decode, PIECEWISE): 100%|██████████| 102/102 [00:15<00:00,  6.72it/s]\n",
      "Capturing CUDA graphs (decode, FULL): 100%|██████████| 102/102 [00:13<00:00,  7.29it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[1;36m(EngineCore_DP0 pid=3440340)\u001b[0;0m INFO 11-20 11:00:22 [gpu_model_runner.py:4240] Graph capturing finished in 30 secs, took 3.21 GiB\n",
      "\u001b[1;36m(EngineCore_DP0 pid=3440340)\u001b[0;0m INFO 11-20 11:00:22 [core.py:250] init engine (profile, create kv cache, warmup model) took 51.07 seconds\n",
      "INFO 11-20 11:00:24 [llm.py:352] Supported tasks: ['generate']\n"
     ]
    }
   ],
   "source": [
    "from vllm import LLM, SamplingParams\n",
    "from vllm.lora.request import LoRARequest\n",
    "import torch\n",
    "from datasets import load_dataset\n",
    "from transformers import AutoTokenizer\n",
    "import pandas as pd\n",
    "\n",
    "\n",
    "def template_dataset(example):\n",
    "    return {\"prompt\": tokenizer.apply_chat_template(example[\"messages\"], tokenize = False, add_generation_prompt = True)}\n",
    "\n",
    "if __name__ == \"__main__\":\n",
    "    base_model_path = \"../base_model/Llama-3.1-8B-Instruct-nf4\"\n",
    "    adapter_path = \"../adapter/Zip-Llama-aligned/policy\"\n",
    "\n",
    "    llm = LLM(\n",
    "        model= base_model_path,\n",
    "        dtype=torch.bfloat16,\n",
    "        trust_remote_code = True,\n",
    "        max_model_len = 32768,\n",
    "        gpu_memory_utilization = 0.3,\n",
    "        enable_lora = True,\n",
    "        max_lora_rank = 64\n",
    "    )\n",
    "\n",
    "    tokenizer = AutoTokenizer.from_pretrained(base_model_path, use_fast = True)\n",
    "    inference_data = load_dataset(\"json\", data_files = \"../data/inference_data.json\", split = \"train\")\n",
    "    inference_data = inference_data.map(template_dataset, remove_columns = [\"messages\"])\n",
    "    prompts = inference_data[\"prompt\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "71307164",
   "metadata": {},
   "outputs": [],
   "source": [
    "sampling_params = SamplingParams(\n",
    "    temperature=0,\n",
    "    max_tokens=512\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "id": "2276f442",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Adding requests: 100%|██████████| 1/1 [00:00<00:00, 70.97it/s]\n",
      "Processed prompts: 100%|██████████| 1/1 [00:01<00:00,  1.25s/it, est. speed input: 2002.06 toks/s, output: 96.13 toks/s]\n"
     ]
    }
   ],
   "source": [
    "output = llm.generate(\n",
    "    [prompts[0]],\n",
    "    sampling_params,\n",
    "    lora_request = LoRARequest(\"adapter\", 1, adapter_path)\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "id": "10501ee2",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'A female patient presented with foot ulcer and hammer toes; on physical examination, BP NA, HR NA, RR NA and Temp NA; admission labs showed WBC 5.6, RBC 4.15, Hgb 11.1, Hct 32.9, Plt NA, MCV 79, MCH 26.6, MCHC 33.6, RDW 13.7, and Glucose 114; the most diagnostically relevant finding was a right submetatarsal ulcer with hammer digit syndrome of the right foot.'"
      ]
     },
     "execution_count": 27,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "output[0].outputs[0].text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "id": "a656dc6e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'A female patient presented with foot ulcer and hammer toes; on physical examination, BP NA, HR NA, RR NA and Temp NA; admission labs showed WBC 5.6, RBC 4.15, Hgb 11.1, Hct 32.9, Plt NA, MCV 79, MCH 26.6, MCHC 33.6, RDW 13.7, and Glucose 114; the most diagnostically relevant finding was a right submetatarsal ulcer with hammer digit syndrome of the right foot.'"
      ]
     },
     "execution_count": 30,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "output[0].outputs[0].text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "id": "657f2163",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "True"
      ]
     },
     "execution_count": 40,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "prompts[0] == output[0].prompt"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "576ffeb6",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Map: 100%|██████████| 10000/10000 [00:43<00:00, 231.17 examples/s]\n"
     ]
    }
   ],
   "source": [
    "gen_ds = gen_ds.map(\n",
    "    lambda example: {\"token_len\": len(tokenizer.apply_chat_template(example[\"messages\"], tokenize = True))}\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "9a574a85",
   "metadata": {},
   "outputs": [],
   "source": [
    "import numpy as np\n",
    "\n",
    "token_len = np.array(gen_ds[\"token_len\"])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "acda10a4",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "np.int64(8922)"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "np.argmax(token_len)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "e0812b0c",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Adding requests:   0%|          | 0/1 [00:00<?, ?it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "WARNING 11-20 11:01:13 [processor.py:246] vLLM has deprecated support for supporting different tokenizers for different LoRAs. By default, vLLM uses base model's tokenizer. If you are using a LoRA with its own tokenizer, consider specifying `--tokenizer [lora_path]` to use the LoRA tokenizer.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Adding requests: 100%|██████████| 1/1 [00:00<00:00, 15.13it/s]\n",
      "Processed prompts: 100%|██████████| 1/1 [00:04<00:00,  4.10s/it, est. speed input: 4194.99 toks/s, output: 29.79 toks/s]\n"
     ]
    }
   ],
   "source": [
    "output = llm.generate(\n",
    "    [prompts[np.argmax(token_len)]],\n",
    "    sampling_params,\n",
    "    lora_request = LoRARequest(\"adapter\", 1, adapter_path)\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "42cf2285",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'<|begin_of_text|><|start_header_id|>system<|end_header_id|>\\n\\nYou are the world’s leading expert in survival analysis. From a discharge summary, extract Chief Complaint, Physical Exam, and Admission Labs (Pertinent Results) and produce one sentence. The sentence will be used for hazard calculation, so be precise, clinically accurate, and concise.<|eot_id|><|start_header_id|>user<|end_header_id|>\\n\\n \\r\\nName:  ___                   Unit No:   ___\\r\\n \\r\\nAdmission Date:  ___              Discharge Date:   ___\\r\\n \\r\\nDate of Birth:  ___             Sex:   M\\r\\n \\r\\nService: MEDICINE\\r\\n \\r\\nAllergies: \\r\\nPatient recorded as having No Known Allergies to Drugs\\r\\n \\r\\nAttending: ___\\r\\n \\r\\nChief Complaint:\\r\\nHeadache\\r\\n \\r\\nMajor Surgical or Invasive Procedure:\\r\\nRight central venous line placement (___)\\r\\n \\r\\nHistory of Present Illness:\\r\\n___ year old male with 3 weeks of worsening headache. Around 4 \\r\\nweeks back he had fevers with sore throat and was found to have \\r\\ntonsillitis and he was treated with clindamycin and prednisone, \\r\\nwhich he completed 2 weeks ago. He then had resolution in the \\r\\nsore throat and fever but continues to have worsening headache \\r\\nwith intermittent blurred vision. He had one episode of mild \\r\\nepistaxis a few days back but no other bleeding from any other \\r\\nsite. However he did notice increased bruising lately. He also \\r\\nnoticed increasing fatigue and dyspnea on exertion. Denies \\r\\nabdominal pain. No change in bowel or bladder habits. No cough. \\r\\nHe has noticed exertional chest pain. Reports sweats and \\r\\noccasional chills. No rashes.\\r\\n     He went to OSH where he was pancytopenic and had a neg Head \\r\\nCT for bleed. He was transferrred to ___ for further w/u and \\r\\nmanagement. In the ED at ___, he got another Head CT which was \\r\\nnegative. A smear was suspicious for APML and was he started on \\r\\nAtra.\\r\\n \\r\\nPast Medical History:\\r\\nRight knee surgery\\r\\nUmbilical and abdominal hernia surgery\\r\\n \\r\\nSocial History:\\r\\n___\\r\\nFamily History:\\r\\nFather has heart disease. No history of anemias or hematologic \\r\\nmalignancy in family.\\r\\n \\r\\nPhysical Exam:\\r\\n97.4, 131/75, 73, 20, 100%/RA\\r\\nGENERAL: alert, pleasant, in mild distress due to headache.\\r\\nHEENT: PERLA, sclera anicteric, oropharynx and tongue pink and \\r\\nmoist\\r\\nwithout lesions.\\r\\nLYMPH: without palpable cervical, axillary, periclavicular\\r\\nlymphadenopathy.\\r\\nLUNGS: clear to auscultation, scattered wheezes. no crackles or\\r\\nrhonchi.\\r\\nCARDIAC: RRR, without murmur, gallop or rub.\\r\\nABDOMEN: soft, non-tender, without hepatosplenomegaly or \\r\\npalpable\\r\\nmasses.\\r\\nEXTREMITIES: without edema, cyanosis or clubbing bilaterally.\\r\\nSKIN: without rashes, petechiae, or ecchymoses. Multiple tatoos\\r\\non body.\\r\\nNEURO: Pupils equal, EOMI, strength full in all 4 extremities.\\r\\n \\r\\nPertinent Results:\\r\\nAdmission Labs:\\r\\n___ 04:10PM   WBC-1.8* RBC-1.19* HGB-4.4* HCT-12.4* \\r\\nMCV-104* MCH-37.1* MCHC-35.7* RDW-19.3*\\r\\n___ 04:10PM   NEUTS-8* BANDS-2 LYMPHS-67* MONOS-0 EOS-0 \\r\\nBASOS-0 ___ METAS-1* MYELOS-1* NUC RBCS-13* OTHER-21*\\r\\n___ 04:10PM   HYPOCHROM-NORMAL ANISOCYT-1+ \\r\\nPOIKILOCY-OCCASIONAL MACROCYT-1+ MICROCYT-OCCASIONAL \\r\\nPOLYCHROM-1+ OVALOCYT-1+ STIPPLED-OCCASIONAL TEARDROP-OCCASIONAL\\r\\n___ 04:10PM   PLT SMR-RARE PLT COUNT-9*\\r\\n___ 04:10PM   ___ PTT-22.4 ___\\r\\n___ 04:10PM   RET AUT-6.0*\\r\\n___ 04:15PM URINE  COLOR-Yellow APPEAR-Clear SP ___\\r\\n___ 04:15PM URINE  BLOOD-SM NITRITE-NEG PROTEIN-NEG \\r\\nGLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.0 \\r\\nLEUK-NEG\\r\\n___ 04:15PM URINE  ___ WBC-1 BACTERIA-RARE YEAST-NONE \\r\\nEPI-0\\r\\n___ 04:10PM   GLUCOSE-95 UREA N-14 CREAT-0.8 SODIUM-138 \\r\\nPOTASSIUM-4.0 CHLORIDE-104 TOTAL CO2-23 ANION GAP-15\\r\\n___ 04:10PM   ALT(SGPT)-8 AST(SGOT)-14 LD(LDH)-256* ALK \\r\\nPHOS-45 TOT BILI-0.3\\r\\n___ 04:10PM   LIPASE-11\\r\\n___ 04:10PM   URIC ACID-4.7\\r\\n___ 04:10PM   HAPTOGLOB-347*\\r\\n.\\r\\nChest radiograph 2-view (___): Heart size is within normal \\r\\nlimits. No focal consolidation is detected within the lungs. No \\r\\neffusion or pneumothorax is present. The pulmonary vascularity \\r\\nis within normal limits.\\r\\n\\r\\nCT head without contrast (___): Unremarkable head CT.\\r\\n\\r\\nBone marrow biopsy (___): INVOLVEMENT by ACUTE \\r\\nPROMYELOCYTIC LEUKEMIA, with t(15;17) (see separate complete \\r\\ncytogenetic report), FAB subtype AML M3. Morphologic and \\r\\nimmunophenotypic findings consistent with involvement by: Acute \\r\\nmyelogenous leukemia.\\r\\n\\r\\nTTE (___):  The left atrium is mildly dilated. Left \\r\\nventricular wall thickness, cavity size and regional/global \\r\\nsystolic function are normal (LVEF 60-70%). There is no \\r\\nventricular septal defect. Right ventricular chamber size and \\r\\nfree wall motion are normal. The aortic valve leaflets (3) \\r\\nappear structurally normal with good leaflet excursion and no \\r\\naortic regurgitation. The mitral valve appears structurally \\r\\nnormal with trivial mitral regurgitation. The estimated \\r\\npulmonary artery systolic pressure is normal. There is no \\r\\npericardial effusion.\\r\\n\\r\\nMR head with/without contrast (___): There is no evidence \\r\\nof mass, mass effect, or hemorrhagic changes. Subtle areas of \\r\\ngyriform enhancement identified in the occipital lobes, possibly \\r\\nconsistent with artifact after the injection of gadolinium \\r\\ncontrast, however, given the history of leukemia, infiltration \\r\\ncannot be completely ruled out.\\r\\n\\r\\nRUE u/s (___): Normal right upper extremity ultrasound \\r\\nexamination. No evidence of DVT.\\r\\n\\r\\nCT pelvis with contrast (___): 1. No evidence for abscess \\r\\nor other etiology to explain the patient\\'s fevers. 2. Umbilical \\r\\nhernia containing omentum.\\r\\n.\\r\\nCytology Report:\\r\\nREPORT APPROVED DATE: ___ \\r\\nSPECIMEN RECEIVED: ___    ___    SPINAL FLUID \\r\\n  \\r\\nSPECIMEN DESCRIPTION: Received specimen in Cytolyt. \\r\\n  Prepared 1 ThinPrep slide. \\r\\n  \\r\\nCLINICAL DATA: Patient with APML now with headache and fever. \\r\\nREPORT TO: ___. ___ \\r\\n  \\r\\n___: Cerebrospinal fluid: \\r\\n    \\r\\n  NEGATIVE FOR MALIGNANT CELLS. \\r\\n    \\r\\n  Monocytes and lymphocytes. \\r\\n    \\r\\n  Note: \\r\\n  Hematology slides (___ and ___, ___ were reviewed \\r\\n  with similar findings. \\r\\nDIAGNOSED BY: \\r\\n ___, ___) \\r\\n___, M.D. \\r\\n.\\r\\nPathology Examination \\r\\n\\r\\nName ___    Age     Sex Pathology #     ___ MRN# \\r\\n___       ___    ___ Male      ___ \\r\\nReport to:   ___. ___ \\r\\n___ by:   ___. ___ \\r\\n\\r\\n \\r\\n\\r\\nSPECIMEN SUBMITTED: immunophenotyping - BM\\r\\n\\r\\nProcedure date     Tissue received     Report Date    Diagnosed \\r\\nby \\r\\n___ ___. ___ \\r\\nPrevious biopsies:    ___  BONE MARROW BIOPSY. (1 JAR) \\r\\n\\r\\nDIAGNOSIS: \\r\\n\\r\\nFLOW CYTOMETRY REPORT \\r\\n\\r\\nFLOW CYTOMETRY IMMUNOPHENOTYPING \\r\\n\\r\\nThe following tests (antibodies) were performed: ___, \\r\\nGlycophorin A, and CD antigens 2, 3, 4, 5, 7, 8, 10, 11c, 13, \\r\\n14, 15, 19, 20, 33, 34, 41, 45, 56, 64, 71, 117.\\r\\n\\r\\n \\r\\n\\r\\nRESULTS:\\r\\n\\r\\n \\r\\n\\r\\nThree color gating is performed (light scatter vs. CD45) to \\r\\noptimize blast yield.\\r\\n\\r\\n \\r\\n\\r\\nCell marker analysis demonstrates that the majority of the cells \\r\\nisolated form this bone marrow express  (56%) are in the \\r\\nintermediate CD45, variable side-scatter region. \\r\\n\\r\\nThey express myeloid associated antigens CD33 and CD117 (subset) \\r\\nalong with CD71, but are negative for immature markers CD34 as \\r\\nwell as ___. \\r\\n\\r\\n___ other myeloid antigens including CD14, CD15, CD41, \\r\\nCD11c, and Glycophorin A. \\r\\n\\r\\nCD4, CD13, CD15 and CD64 are equivocal with a suggestion of \\r\\nextremely dim staining in a subset.\\r\\n\\r\\nThey lack B and T cell associated antigens and are CD10 (cALLa) \\r\\nnegative. A minor subset (2%) co-express lymphoid associated \\r\\nantigens CD2.\\r\\n\\r\\n \\r\\n\\r\\nOf the lymphoid gated events, B cells comprise 28% of gated \\r\\nevents, are polyclonal, and do not express aberrant antigens. \\r\\n\\r\\nT cells comprise 57% of lymphoid gated events and express mature \\r\\nlineage antigens.\\r\\n\\r\\n \\r\\n\\r\\n \\r\\n\\r\\nINTERPRETATION\\r\\n\\r\\n \\r\\n\\r\\nMorphologic and immunophenotypic findings consistent with \\r\\ninvolvement by: Acute myelogenous leukemia.  \\r\\n\\r\\nCorrelation with morphology (___) and cytogenetics is \\r\\nrecommended for exact subclassification. \\r\\n\\r\\n \\r\\n\\r\\nNote: This test was performed using analyte specific reagents \\r\\n(ASRs).  These ASRs have not been cleared or approved by the ___ \\r\\nFood and Drug Administration (FDA).  However, the FDA has \\r\\ndetermined that such clearance or approval is not necessary.  \\r\\nThis test was developed and its performance characteristics \\r\\ndetermined by the Flow Cytometry Laboratory at ___ \\r\\n___, which is licensed by ___ to perform \\r\\nhigh complexity tests.  This test was used for clinical \\r\\npurposes; it should not be regarded as for research.\\r\\n\\r\\n.\\r\\n.\\r\\nPathology Examination \\r\\n\\r\\nName ___    Age     Sex Pathology #     ___ MRN# \\r\\n___       ___    ___ Male      ___ \\r\\nReport to:   ___. ___ \\r\\n___ by:   ___. ___ \\r\\n\\r\\n \\r\\n\\r\\nSPECIMEN SUBMITTED: BONE MARROW BIOPSY. (1 JAR)\\r\\n\\r\\nProcedure date     Tissue received     Report Date    Diagnosed \\r\\nby \\r\\n___ ___. ___ \\r\\n\\r\\nSPECIMEN: BONE MARROW ASPIRATE AND CORE BIOPSY:\\r\\n\\r\\n \\r\\n\\r\\nDIAGNOSIS: \\r\\n\\r\\nINVOLVEMENT by ACUTE PROMYELOCYTIC LEUKEMIA, with t(15;17) (see \\r\\nseparate complete cytogenetic report), FAB subtype AML M3.  \\r\\n\\r\\n                                                                 \\r\\n\\r\\n\\r\\n \\r\\n\\r\\nMICROSCOPIC DESCRIPTION\\r\\n\\r\\nPeripheral Blood Smear:  \\r\\n\\r\\nThe smear is adequate for evaluation.  Erythrocytes are markedly \\r\\ndecreased with hypochromasia, polychromasia, and anisocytosis \\r\\nincluding dacrocytes present.  Nucleated red cells are present.  \\r\\n The white blood cell count appears decreased; several atypical \\r\\npromyelocytes/blasts with bilobed nuclei, cytoplasmic granules \\r\\nand occasional with Auer rods are seen.  \\r\\n\\r\\nPlatelet count appears markedly decreased; large and giant forms \\r\\nare not present.  Differential count shows 11% neutrophils,  1% \\r\\nmonocytes,  46% lymphocytes,  33% atypical promyelocytes/blasts, \\r\\n10% myelocytes.   \\r\\n\\r\\n \\r\\n\\r\\nAspirate Smear:\\r\\n\\r\\nThe aspirate material is adequate for evaluation  and is \\r\\ncomposed of many markedly hypercellular spicules, with sheets of \\r\\natypical promyelocytes/blasts some of which have Auer rods.  \\r\\n\\r\\nMaturing erythroid precursors are markedly decreased, with some \\r\\ndemonstrating nuclear membrane irregularities.  Maturing myeloid \\r\\nprecursors appear markedly decreased in number.   Megakaryocytes \\r\\nare present in  markedly decreased numbers.  \\r\\n\\r\\nDifferential (300 cells) shows:  70%  Blasts/ Atypical \\r\\nPromyelocytes, 2% Myelocytes, 3% Metamyelocytes,  1%  \\r\\nBands/Neutrophils, 1% Plasma cells,  12% Lymphocytes, 10% \\r\\nErythroid.\\r\\n\\r\\n \\r\\n\\r\\nBiopsy Slides:  \\r\\n\\r\\nThe biopsy material is  adequate for evaluation, however \\r\\nconsists of a small (0.9 cm) primarily cartilage cortical bone, \\r\\na small portion of subcortical marrow.  It is hypercellular \\r\\n(90%) consisting mostly of atypical promyelocytes/blasts \\r\\noccurring in sheets occupying 80 - 90% of marrow cellularity. .  \\r\\nThere is scant remaining trilineage hematosis.   \\r\\n\\r\\nMarrow clot section is not submitted.    Touch prep is not \\r\\nsubmitted.  \\r\\n\\r\\n \\r\\n\\r\\nSpecial Stains:\\r\\n\\r\\nIron stain is adequate  for evaluation.  Storage iron is \\r\\ndecreased.   Rare sideroblasts are present.   Ring sideroblasts \\r\\nare absent.  \\r\\n\\r\\n \\r\\n\\r\\nADDITIONAL STUDIES:\\r\\n\\r\\nCytogenetics (please see separate report).   \\r\\n\\r\\nFlow cytometry studies (please see separate report).\\r\\nDischarge Labs:\\r\\nWBC RBC Hgb Hct MCV MCH MCHC RDW Plt Ct \\r\\n___ 08:08AM    3.9*1 3.53* 11.0* 30.0* 85 31.1 36.5* \\r\\n16.0* 401 \\r\\n___ 06:20AM    3.5*2 3.40* 10.5* 29.1* 86 31.0 36.2* \\r\\n15.7* 393 \\r\\n___ 05:45AM    3.0* 3.27* 10.1* 27.9* 85 30.9 36.2* \\r\\n15.8* 359 \\r\\n___ 06:24AM    2.5*2 3.12* 9.5* 26.1* 84 30.4 36.3* \\r\\n15.7* 298 \\r\\n___ 12:10AM    2.1* 3.04* 9.4* 25.3* 83 30.9 37.2* 14.9 \\r\\n235 \\r\\n___ 12:00AM    2.3* 3.19* 9.6* 26.7* 84 30.2 36.1* 14.7 \\r\\n188 \\r\\n___ 12:15AM    2.3*1 3.28* 10.1* 27.5* 84 30.9 36.9* \\r\\n14.5 133*# \\r\\n___ 12:30AM    1.8*3 3.52* 10.6* 28.9* 82 30.0 36.6* \\r\\n14.3 84*# \\r\\n___ 12:00AM    1.7*1 3.19* 9.9* 26.0* 81* 31.0 38.1*4 \\r\\n13.9 49* \\r\\n___ 12:20AM    1.4*3 3.30* 10.2* 27.0* 82 31.0 37.9* \\r\\n14.1 38* \\r\\n___ 12:38AM    1.0*1 2.99* 9.2* 23.9* 80* 30.7 38.4* \\r\\n14.2 40* \\r\\n___ 12:00AM    1.0*5 2.78* 8.7* 22.7* 82 31.2 38.2* 14.9 \\r\\n17* \\r\\n___ 12:10AM    1.0*1 3.06* 9.6* 25.5* 84 31.2 37.4* 14.9 \\r\\n33* \\r\\n___ 12:27AM    0.9*6 2.76* 8.8* 22.7* 82 31.8 38.6* 15.3 \\r\\n15* \\r\\n___ 12:00AM    0.8* 2.90* 9.0* 24.2* 83 31.0 37.2* 15.2 \\r\\n26* \\r\\n___ 12:13AM    0.9*7 2.91* 8.9* 24.1* 83 30.6 37.0* 15.2 \\r\\n39* \\r\\n___ 12:00AM    0.9*3 2.99* 9.1* 24.8* 83 30.6 36.8* 15.0 \\r\\n53* \\r\\n___ 12:00AM    0.6* 2.63* 8.4* 22.1* 84 32.0 38.1* 15.5 \\r\\n76*2 \\r\\n___ 12:00AM    0.8*3 2.98* 9.3* 25.1* 84 31.1 37.0* \\r\\n15.6* 128* \\r\\n___ 12:00AM    0.8* 2.95* 9.2* 25.1* 85 31.1 36.5* 15.7* \\r\\n71* \\r\\n___    0.9*1 2.78* 8.8* 24.0* 86 31.8 36.8* \\r\\n16.4* 51* \\r\\n___    1.0*3 2.91* 9.3* 24.7* 85 32.1* 37.8* \\r\\n16.3* 26* \\r\\n___    1.0*8 2.74* 8.8* 23.6* 86 32.1* 37.1* \\r\\n16.9* 35* \\r\\n___    0.9* 2.59* 8.2* 22.2* 86 31.6 36.8* 17.1* \\r\\n28* \\r\\n___    1.1*2 2.58* 8.2* 22.4* 87 32.0 36.8* \\r\\n17.8* 45* \\r\\n___    1.19*9 2.70* 8.6* 23.3* 86 31.9 37.0* \\r\\n17.7* 66* \\r\\n___    0.86*9 2.83* 8.9* 24.8* 88 31.3 35.7* \\r\\n17.3* 94*# \\r\\n___    1.7*1 3.38* 10.5* 29.6* 88 31.1 35.5* \\r\\n17.2* 39* \\r\\n___    1.5*2 2.99* 9.6* 26.8* 89 32.1* 35.9* \\r\\n18.3* 48* \\r\\n___    1.6*#10 3.19* 10.0* 28.8* 90 31.4 34.7 \\r\\n18.5* 41* \\r\\n___    4.52 3.38* 10.7* 30.3* 90 31.6 35.3* \\r\\n18.4* 53* \\r\\n___    5.23 3.04* 9.7* 27.1* 89 32.0 35.9* 18.5* \\r\\n61* \\r\\n___    6.3 3.10* 9.9* 27.8* 90 32.1* 35.8* 18.6* \\r\\n58* \\r\\n___    7.611 2.98* 9.7* 27.2* 91 32.5* 35.7* \\r\\n18.8* 61* \\r\\n___    7.91 2.91* 9.4* 26.3* 91 32.3* 35.7* \\r\\n19.3* 60* \\r\\n___    6.1 3.10* 9.8* 27.5* 89 31.7 35.7* 18.7* \\r\\n60* \\r\\n___    9.691 2.96* 9.3* 26.5* 89 31.4 35.1* \\r\\n18.9* 59* \\r\\n___    10.01 2.59* 8.4* 23.1* 89 32.3* 36.3* \\r\\n19.5* 62* \\r\\n___    10.33 2.64* 8.7* 23.4* 89 32.9* 37.2* \\r\\n19.8* 73* \\r\\n___    8.4 2.77* 9.0* 24.5* 89 32.7* 36.9* 19.4* \\r\\n75* \\r\\n___    8.42 2.89* 9.2* 25.5* 88 31.8 36.1* 19.5* \\r\\n93* \\r\\n___    8.9#8 3.03* 9.8* 26.6* 88 32.2* 36.7* \\r\\n19.5* 46* \\r\\n___    4.712 2.80* 9.0* 24.6* 88 32.2* 36.6* \\r\\n20.5* 46* \\r\\n___    5.0 2.91* 9.4* 25.2* 87 32.2* 37.2* 20.2* \\r\\n59* \\r\\n___    4.313 3.25* 10.3* 28.2* 87 31.6 36.3* \\r\\n20.0* 39* \\r\\n___    3.6*14 2.75* 9.0* 24.0* 87 32.8* 37.6* \\r\\n20.3* 58* \\r\\n___    3.5*14 2.42*# 8.0*# 21.7*# 90 32.8* 36.7* \\r\\n20.0* 40* \\r\\n___    2.8*#15 1.73* 5.9* 16.6* 96 34.2* 35.6* \\r\\n20.8* 41* \\r\\n___    1.7*16 1.47* 5.1* 14.6* 99* 34.8* 35.0 \\r\\n20.9* 37*# \\r\\n___    1.8*17 1.19* 4.4* 12.4*18 104* 37.1* \\r\\n35.7* 19.3* 9*19\\r\\n.\\r\\nDIFF Neuts Band Lymph Mono Eos Baso Atyps Metas Myelos Promyel \\r\\nBlasts NRBC Other \\r\\n___ 08:08AM    38* 1 43* 13* 0 1 2* 2* 0     1*   \\r\\n___ 06:20AM    31* 0 43* 21* 0 0 2* 1* 2*         \\r\\n___ 05:45AM    40*1 0 40 20* 0 0 0 0 0         \\r\\n___ 06:24AM    15* 1 42 37* 0 0 1* 2* 2*     1*   \\r\\n___ 12:10AM    8* 0 33 23* 0 0 35* 1* 0         \\r\\nSource: Line-cvl \\r\\n___ 12:00AM    4* 0 46* 38* 0 0 10* 0 0     1* 2*2 \\r\\nSource: Line-central \\r\\n___ 12:15AM    0 0 58* 42* 0 0 0 0 0     1*   \\r\\nSource: Line-TLCL \\r\\n___ 12:30AM    0 0 64*3 36* 0 0 0 0 0         \\r\\n___ 12:00AM    0 0 74* 24* 0 0 2* 0 0         \\r\\n___ 12:20AM    0 0 76*3 24* 0 0 0 0 0         \\r\\n___ 12:38AM    2*1 0 ___ 0 05 0 0       3*6 \\r\\n___ 12:00AM    0*1 0 92* 6 0 0 2* 0 0         \\r\\nSource: Line-TLCL \\r\\n___ 12:10AM    2*1 0 96* 0 0 0 2* 0 0         \\r\\nSource: Line-cvl \\r\\n___ 12:27AM    0*1 0 86* 0 0 0 14* 0 0         \\r\\nSource: Line-TLCL \\r\\n___ 12:00AM    2*7 0 94* 0 0 0 4* 0 0         \\r\\nSource: Line-tlcl \\r\\n___ 12:13AM    0*1 0 96* 0 0 0 4* 0 0         \\r\\nSource: Line-tlcl \\r\\n___ 12:00AM    8*3 0 92* 0 0 0 0 0 0         \\r\\n___ 12:00AM    4*3 0 96* 0 0 0 0 0 0         \\r\\nSource: Line-TLCL \\r\\n___ 12:00AM    11.2* 0 80.5* 1.2* 5.9* 1.2               \\r\\n\\r\\n___    9.0*   82.4* 0.6* 7.4* 0.5               \\r\\n___    2* 0 92* 4 0 0 1* 0 0       1*8 \\r\\nSource: Line-Hickman \\r\\n___    2* 0 91* 0 0 0 4* 0 0       3*9 \\r\\nSource: Line-TLCL \\r\\n___    10*1 0 60* 0 0 0 30* 0 0         \\r\\nSource: Line-cvl \\r\\n___    20*1 0 67* 2 0 0 11* 0 0     2*   \\r\\nSource: Line-TLCL \\r\\n___    39*1 0 55* 3 0 0 3* 0 0         \\r\\n___    40*10 0 56* 1* 0 0 3* 0 0         \\r\\nSource: Line-TLCL \\r\\n___    18* 0 70* 11 0 0 1* 0 0   0     \\r\\nSource: Line-tlcl \\r\\n___    ___ 1* 0 0 0 0 2* 1*12       \\r\\nSource: Line-TLCL \\r\\n___    42* ___ 0 0 0 2* 7*     1* 14*13 \\r\\nSource: Line-TLCL \\r\\n___    36*14 ___ 7* 9*   4*   \\r\\nSource: Line-TLCL \\r\\n___    20*16 ___ 0 0 0 0 12*20 24*21   \\r\\n2* 022 \\r\\nSource: Line-cvl \\r\\n___    20*23 8*20 12*24 0*19 0 0 0 24*19 12*21 \\r\\n24*20     025 \\r\\nSource: Line-TLCL \\r\\n___    5* ___ 0 0 0 7* 19* 8*   7* 40*26 \\r\\n___    5* ___ 0 0 0 4* 20* 37*27 0   0 \\r\\n___    4* 0 23 2 0 0 0 7* 18* 4*   13* 42*28 \\r\\nSource: Line-TLCL \\r\\n___    8* 0 49* 12* 0 0 0 1* 0 0   17* 30*28 \\r\\n___    8* 2 67* 0 0 0 0 1* 1*     13* 21*29 \\r\\n.\\r\\nFibrino FDP \\r\\n___ 12:00AM    565*   \\r\\nSource: Line-TLCL \\r\\n___ 12:00AM    567*   \\r\\n___    617*   \\r\\n___    541*   \\r\\nSource: Line-TLCL \\r\\n___    543*   \\r\\nSource: Line-TLCL \\r\\n___    498*   \\r\\nSource: Line-TLCL \\r\\n___    389   \\r\\n___    329#   \\r\\nSource: Line-TLCL \\r\\n___      ___ \\r\\nSource: Line-tlcl \\r\\n___    192   \\r\\nSource: Line-tlcl \\r\\n___      ___ \\r\\n___    195   \\r\\nSource: Line-TLCL \\r\\n___    193   \\r\\n___      ___ \\r\\nSource: Line-TLCL \\r\\n___    161   \\r\\nSource: Line-TLCL \\r\\n___      ___ \\r\\nSource: Line-TLCL \\r\\n___    204   \\r\\nSource: Line-TLCL \\r\\n___      40-80* \\r\\nSource: Line-TLCL \\r\\n___    209   \\r\\nSource: Line-TLCL \\r\\n___      ___ \\r\\nSource: Line-cvl \\r\\n___    183   \\r\\nSource: Line-cvl \\r\\n___      40-80* \\r\\n___    262   \\r\\n___      ___ \\r\\nSource: Line-TLCL \\r\\n___    231   \\r\\nSource: Line-TLCL \\r\\n___      ___ \\r\\n___    188   \\r\\n___      ___ \\r\\nSource: Line-TLCL \\r\\n___    236   \\r\\nSource: Line-TLCL \\r\\n___      ___ \\r\\n___    255   \\r\\nSource: Line-TLCL \\r\\n___      80-160* \\r\\n___    234   \\r\\n___      80-160* \\r\\n___    207   \\r\\n___      80-160* \\r\\nSource: Line-TLCL \\r\\n___    163   \\r\\nSource: Line-TLCL \\r\\n___      80-160* \\r\\n___    192   \\r\\n___      80-160* \\r\\n___    183   \\r\\nFIBR ADDED 11;38AM \\r\\n___      320-640* \\r\\n___    182   \\r\\n___      320-640* \\r\\n___    167   \\r\\n___      320-640* \\r\\n___    162   \\r\\n___      80-160* \\r\\n___    176   \\r\\n.\\r\\nRENAL & GLUCOSE Glucose UreaN Creat Na K Cl HCO3 AnGap \\r\\n___ 08:08AM    138* 15 0.6 138 4.2 99 27 16 \\r\\n___ 06:20AM    124* 15 0.6 137 4.5 100 26 16 \\r\\nALB ADDED ___ @ 09:07 \\r\\n___ 05:45AM    ___ 141 4.3 ___ \\r\\n___ 06:24AM    150* 10 0.7 139 4.0 ___ \\r\\n___ 12:10AM    111* 13 0.6 138 4.0 ___ \\r\\nSource: Line-cvl \\r\\n___ 12:00AM    ___ 135 4.1 98 29 12 \\r\\nSource: Line-central \\r\\n___ 12:15AM    97 15 0.6 135 4.1 99 28 12 \\r\\nSource: Line-TLCL \\r\\n___ 12:30AM    ___ 138 3.9 100 27 15 \\r\\n___ 12:00AM    109* 16 0.6 139 3.7 102 30 11 \\r\\n___ 12:20AM    93 16 0.7 139 4.0 ___ \\r\\n___ 12:38AM    117* 15 0.7 139 4.2 102 31 10 \\r\\n___ 12:00AM    108* 16 0.6 136 4.1 100 28 12 \\r\\nSource: Line-TLCL \\r\\n___ 12:10AM    110* 14 0.6 137 4.3 99 30 12 \\r\\nSource: Line-cvl \\r\\n___ 12:27AM    96 15 0.7 137 4.2 98 29 14 \\r\\nSource: Line-TLCL \\r\\n___ 12:00AM    98 15 0.7 136 4.1 97 29 14 \\r\\nSource: Line-tlcl \\r\\n___ 12:13AM    ___ 137 3.9 98 32 11 \\r\\nSource: Line-tlcl \\r\\n___ 12:00AM    ___ 139 4.1 100 30 13 \\r\\nADD ON \\r\\n___ 12:00AM    111* 13 0.6 139 3.9 99 29 15 \\r\\n___ 12:00AM    108* 16 0.7 139 4.4 100 29 14 \\r\\nSource: Line-TLCL \\r\\n___ 12:00AM    122* 15 0.6 135 3.7 98 27 14 \\r\\n___    122* 12 0.6 135 3.9 96 31 12 \\r\\n___    ___ 135 4.3 97 30 12 \\r\\nSource: Line-TLCL \\r\\n___    ___ 138 4.3 99 30 13 \\r\\nSource: Line-Hickman \\r\\n___    ___ 133 4.0 98 25 14 \\r\\nSource: Line-TLCL \\r\\n___    ___ 134 4.0 98 28 12 \\r\\nSource: Line-cvl \\r\\n___    ___ 137 4.0 98 30 13 \\r\\nSource: Line-TLCL \\r\\n___    113* 15 0.6 133 4.3 96 30 11 \\r\\n___    92 17 0.5 133 4.2 95* 28 14 \\r\\nSource: Line-TLCL \\r\\n___    101 23* 0.7 1351 3.91 991 281 12 \\r\\nSource: Line-tlcl \\r\\n___    ___ 139 4.2 ___ \\r\\nSource: Line-TLCL \\r\\n___    139* 23* 0.7 137 4.3 ___ \\r\\n___    114* 24* 0.7 137 4.1 100 30 11 \\r\\nSource: Line-TLCL \\r\\n___    136* 21* 0.7 136 4.2 99 25 16 \\r\\nSource: Line-TLCL \\r\\n___          140 3.8 103     \\r\\nSource: Line-TLCL \\r\\n___    119* 17 0.8 138 3.9 ___ \\r\\nSource: Line-cvl \\r\\n___          138 4.2 102     \\r\\n___    151* 18 0.8 137 4.4 ___ \\r\\nSource: Line-TLCL \\r\\n___            3.6       \\r\\n___    118* 17 0.8 141 3.6 ___ \\r\\n___          141 3.8 104     \\r\\nSource: Line-TLCL \\r\\n___          137 3.9 102     \\r\\nSource: Line-TLCL \\r\\n___    148* 11 0.9 138 4.4 ___ \\r\\n___          137 3.7 102     \\r\\n___    115* 13 0.8 135 3.6 100 25 14 \\r\\nSource: Line-TLCL \\r\\n___            4.1       \\r\\n___    112* 13 0.8 140 3.8 ___ \\r\\n___            3.6       \\r\\n___        0.7   4.1       \\r\\n___    116* 15 0.8 135 4.1 ___ \\r\\n___    95 14 0.8 138 4.0 ___ \\r\\n.\\r\\nENZYMES & BILIRUBIN ALT AST LD(LDH) CK(CPK) AlkPhos Amylase \\r\\nTotBili DirBili \\r\\n___ 08:08AM    16 18 171   128*   0.2   \\r\\n___ 12:00AM    25 21     116   0.3   \\r\\nSource: Line-central \\r\\n___ 12:15AM    29 19     122*   0.3   \\r\\nSource: Line-TLCL \\r\\n___ 12:30AM    33 22 191   130*   0.3   \\r\\n___ 12:00AM    37 26 174   115   0.4   \\r\\n___ 12:20AM    42* 28 181   113   0.5   \\r\\n___ 12:38AM    49* 35 166   97   0.6   \\r\\n___ 12:00AM    58* 46* 162   89   0.5   \\r\\nSource: Line-TLCL \\r\\n___ 12:10AM    59* 41* 171   93   0.6   \\r\\nSource: Line-cvl \\r\\n___ 12:27AM    59* 38 147   76   0.6   \\r\\nSource: Line-TLCL \\r\\n___ 12:00AM    62* 31 153   72   0.5   \\r\\nSource: Line-tlcl \\r\\n___ 12:13AM    77* 44* 152   69   0.4   \\r\\nSource: Line-tlcl \\r\\n___ 12:00AM    101* 74* 185   67   0.7   \\r\\nADD ON \\r\\n___ 12:00AM    55* 51*     64   0.6   \\r\\n___ 12:00AM    23 23     65   0.4   \\r\\nSource: Line-TLCL \\r\\n___ 12:00AM    25 24 185   63   0.5   \\r\\n___    23 23 189   61   0.4   \\r\\n___    24 27 206   57   0.7   \\r\\nSource: Line-TLCL \\r\\n___    23 29 217   56   0.7   \\r\\nSource: Line-Hickman \\r\\n___    20 18 162   51   0.7   \\r\\nSource: Line-TLCL \\r\\n___    24 21 173   56   0.4   \\r\\nSource: Line-cvl \\r\\n___    26 18 186   60   0.4   \\r\\nSource: Line-TLCL \\r\\n___    24 20 177   55   0.4   \\r\\n___    27 17 187   59   0.4   \\r\\nSource: Line-TLCL \\r\\n___    28 13 201   59   0.3   \\r\\nSource: Line-tlcl \\r\\n___    32 12 201   53   0.3   \\r\\nSource: Line-TLCL \\r\\n___    53* 19 283*   65 31 0.5   \\r\\n___    64* 24 316*   60   0.5   \\r\\nSource: Line-TLCL \\r\\n___    87* 45* 423*   65   0.7   \\r\\nSource: Line-TLCL \\r\\n___    76* 53* 413*   64   0.5   \\r\\nSource: Line-cvl \\r\\n___    33 31 428*   58   0.7   \\r\\nSource: Line-TLCL \\r\\n___    21 21 385*   50   0.5   \\r\\n___    21 22 403*   56   0.8   \\r\\n___    17 19 344*   53   0.7   \\r\\nSource: Line-TLCL \\r\\n___    19 22 366*   56   1.0   \\r\\n___    ___   47   1.3   \\r\\n___    ___   45   0.3   \\r\\n.\\r\\nHEMATOLOGIC calTIBC VitB12 Folate Hapto Ferritn TRF \\r\\n___    ___ 277 \\r\\n___         7.2       \\r\\n___          347*     \\r\\n.\\r\\nPITUITARY TSH \\r\\n___    3.5\\r\\n.\\r\\nHEPATITIS HBsAg HBsAb HBcAb \\r\\n___ 12:00AM    NEGATIVE BORDERLINE1 NEGATIVE\\r\\n.\\r\\nHIV SEROLOGY HIV Ab \\r\\n___    NEGATIVE\\r\\n.\\r\\n DIPSTICK URINALYSIS Blood Nitrite Protein Glucose Ketone \\r\\nBilirub Urobiln pH Leuks \\r\\n___    NEG NEG NEG NEG NEG NEG NEG 6.0 NEG \\r\\n___    TR NEG NEG NEG TR NEG 2* 5.5 NEG \\r\\nSource: ___ \\r\\n___    MOD NEG 30 NEG NEG SM  8* 6.5 NEG \\r\\nSource: ___ \\r\\n___    SM NEG NEG NEG NEG NEG NEG 6.0 NEG\\r\\n.\\r\\n ANALYSIS WBC RBC Polys Lymphs Monos \\r\\n___ 11:13AM    6 166* 01 56 44 \\r\\n# 4 \\r\\n___ 11:13AM    5 1825* 02 50 50 \\r\\n.\\r\\nCHEMISTRY TotProt Glucose LD(LDH) \\r\\n___ 11:13AM    26 58 30 \\r\\nTUBE # 1; TUBE # 2\\r\\n.\\r\\n___ 11:13AM \\r\\nHERPES SIMPLEX VIRUS PCR \\r\\n  Test Name                        Result           Reference \\r\\nRange\\r\\n---------                        ------           \\r\\n---------------\\r\\nHerpes Simplex Virus ___ Detection and Diff, PCR\\r\\n   HSV 1 DNA                   Not Detected        Not Detected\\r\\n   HSV 2 DNA                   Not Detected        Not Detected\\r\\n  \\r\\nThis test was developed and its performance characteristics have \\r\\nbeen\\r\\ndetermined by Focus Diagnostics. Performance characteristics \\r\\nrefer to the\\r\\nanalytical performance of the test.\\r\\n     \\r\\nThis test is performed pursuant to a license agreement with \\r\\n___\\r\\nMolecular ___, ___.\\r\\n.\\r\\n\\r\\n \\r\\n \\r\\n\\r\\n \\r\\nBrief Hospital Course:\\r\\n___ year old male with new diagnosis APML admitted on ___. Hospital course was as follows.\\r\\n\\r\\n1. APML:  Patient was admitted from an OSH with headache and \\r\\nblurry vision and found to have a significant proportion of \\r\\nabnormal promyelocytes on peripheral smear. Treatment for APML \\r\\nwith Atra was empirically started. The patient required several \\r\\npRBC transfusions for severe anemia as well as platelets on \\r\\nadmission. Subsequent bone marrow biopsy confirmed diagnosis of \\r\\nAPML with t(15;17). Patient underwent induction with idarubicin \\r\\nover eight days without further complication. Laboratory data \\r\\ninitially revealed low grade DIC (FDP 320-640, Fibrinogen 162), \\r\\nnever requiring cryoprecipitate. Given intermittent headaches \\r\\nand likelihood of leukemic infiltration into the CNS, patient \\r\\nunderwent CT-guided lumbar puncture (after failed at bedside) on \\r\\n___. Prior MR and CT imaging of head were without \\r\\nabnormality. During the LP on ___, the pt received one dose of \\r\\nintrathecal methotrexate. The LP was subsequently negative for \\r\\nsigns of malignancy. The patient was continued on Atra until his \\r\\ncounts returned through the end of his hospitalization on \\r\\n___.\\r\\n.\\r\\n2. Febrile Neutropenia:  Early in hospital course patient was \\r\\nnoted to have drainage from umbilicus and reported previous \\r\\nabdominal hernia repair. Patient\\'s OSH surgeon, Dr. ___ in \\r\\n___, informed team of initial plans for taking patient \\r\\nto surgery for repeat abdominal hernia repair and removal of \\r\\npotentially infected sutures. Surgery team was consulted and, \\r\\ngiven the need for patient to begin treatment for APML, decision \\r\\nwas made to hold off on surgical intervention. Patient was \\r\\nstarted on meropenem and fluconazole for empiric coverage. Once \\r\\npatient became febrile, vancomycin was also added. Area was \\r\\ndressed daily. CT pelvis did not reveal extension of sinus into \\r\\nabdomen. One wound swab from ___ revealed pan-sensitive Coag + \\r\\nstaph and diphtheroids. The patient was changed from fluconazole \\r\\nto caspofungin (which was associated with a transient rise in \\r\\nhis transaminases) and subsequently changed to voriconazole. The \\r\\npt was also put briefly on IV flagyl for further anerobic \\r\\ncoverage. \\r\\n     Thorough investigation once neutropenic fever started did \\r\\nnot reveal any infectious source other than draining umbilicus. \\r\\nAll blood cultures, urine cultures, and imaging data negative \\r\\nwere negative to date. \\r\\n\\r\\n3. Bilateral intraretinal hemorrhage - The pt presented with \\r\\nblurred vision. Bilateral intraretinal hemorrhages were on \\r\\nadmission by ophthalmology. The patients symptoms slowly \\r\\nimproved throughout hospital course. Initially maintained \\r\\nplatelets above 30,000 to try to prevent bleeding. The patient \\r\\nwas continued artificial tears through his hospital course as \\r\\nneeded. At the time of discharge the patients symptoms had \\r\\ncompletely resolved. The patient was given the option to \\r\\nfollow-up with ophthalmology as outpatient.\\r\\n.\\r\\n4. Headache and Back Pain: The pt reported chronic left sided \\r\\nheadaches with associated visual changes and eye pain during his \\r\\nhospitalization. In the setting of low platelets, the pt\\'s head \\r\\nwas scanned for intracranial bleed, and found to be negative. \\r\\nThe patient also complained of pinpoint, pleuritic subscapular \\r\\nback pain (which was later ruled out for PE and dissection, and \\r\\nalleviated by flexeril). Neurology was consulted for the \\r\\npatients headache. The team stated that the patients pain was \\r\\nthought to be secondary to tension. The patient was started on \\r\\ndiazepam which alleviated his symtoms over the course of a few \\r\\ndays. The patient was given information to follow-up with a \\r\\nneurologist closer to his home.\\r\\n\\r\\n5. Smoking Cessation: Patient with a ten pack smoking history. \\r\\nWas placed on 21mg patch for a few weeks while as an inpatient. \\r\\nThis was tapered down to 14mg for the final week of the patients \\r\\nhospitalization. The patient was counselled on the importance of \\r\\nsmoking cessation. This should be followed and reiterated at his \\r\\nnext physicians appointment.\\r\\nNeurology Consult:\\r\\n\\r\\nDate: ___\\r\\nSigned by ___, MD on ___  Affiliation: \\r\\n___\\r\\nCosigned by ___, MD on ___\\r\\n \\r\\nReason for consult:  headache \\r\\n\\r\\nHPI: The pt is a ___ year-old right-handed man with a recent\\r\\ndiagnosis of acute promyelocytic leukemia. Ms. ___ has had\\r\\nintermittent headaches since his early ___ however in the\\r\\nlast month he has had almost daily, severe headaches. \\r\\n\\r\\nIn the past, Mr. ___ headaches were characterized by severe\\r\\nthrobbing pain located bifrontally. The headaches would occur\\r\\nevery ___ months and last for about a day. He would frequently\\r\\ncome to an ED for treatment if his headache was very severe and\\r\\nreceive IV medications. He is not certain what medications he \\r\\nwas\\r\\ngiven but recognizes the names ___, morphine and ___. \\r\\nHe\\r\\ndid not find that any of these medications resolved his pain,\\r\\nhowever it would often \"take the edge off\". The pain would\\r\\nusually improve with medicines and sleep and he would awaken the\\r\\nfollowing day without a headache. He has also tried OTC\\r\\nanalgesics including Tylenol, ibuprofen, Advil migraine and\\r\\noccasional Tylenol with codeine and Percocet. \\r\\n\\r\\nHis headaches were also associated with photophobia but no\\r\\nphonophobia, nausea or vomiting. He also described occasional\\r\\nscotomas characterized by \"black flies\" in his peripheral \\r\\nvision.\\r\\nThe headaches also had a prodrome in which he could tell the\\r\\nheadache was coming. He has not been able to identify any\\r\\ntriggers but found that Valsalva, cough and bending over \\r\\nworsened\\r\\nthe pain. He also noted associated neck pain with his headaches.\\r\\nHe denied any vision loss, weakness or numbness with his\\r\\nheadaches. He has noted that the pain awakens him from sleep. He\\r\\nwas never evaluated for his headaches beyond his visits to the \\r\\nED\\r\\nand has never tried a triptan or chronic daily headache therapy.\\r\\n\\r\\nIn ___ of this year, he developed spiking fevers to 103.9. \\r\\nHe\\r\\nwent to an OSH ED and was diagnosed with pharyngitis and\\r\\ndischarged on antibiotics. Several weeks later, his fevers\\r\\nimproved but he developed a severe L frontal headache. This pain\\r\\nhas been persistent since its onset. He describes the HA as\\r\\ndifferent from his prior headache. His current headache is\\r\\ncharacterized by a throbbing pain bilaterally and frontally,\\r\\nworse on the L. It is also associated with neck stiffness and\\r\\ntightness. He has photophobia without phonophobia, nausea or\\r\\nvomiting. The pain is also worsened by Valsalva and lying down.\\r\\nSleep does not seem to resolve the pain. He has also noted\\r\\nworsening fatigue with these headaches. \\r\\n\\r\\nPrior to his hospitalization, Mr. ___ tried multiple ___\\r\\nanalgesics for his pain and took them almost daily without\\r\\nrelief. Since his admission, he has been treated with morphine,\\r\\nDilaudid and Compazine without relief. He has found oxycodone\\r\\nhelpful and is waiting to try Fioricet. He was treated with\\r\\nFlexeril for back pain and Ativan prior to his LP but does not\\r\\nrecall either of these medications improving his headache. \\r\\n\\r\\nHis ROS is otherwise remarkable intermittent bilateral blurry\\r\\nvision and central vision loss which has now improved. He was\\r\\ndiagnosed with bilateral retinal artery hemorrhages. He has also\\r\\nnoted intermittent L sided jaw pain and clicking. He denies a\\r\\nhistory of bruxism but notes that he is missing his lower teeth.\\r\\nHe also notes chronic pain and tightness in his neck on the L \\r\\nand\\r\\nfinds that cracking his neck at times relives the pain. \\r\\n\\r\\nHe only consumes caffeine ___ times per day and denies heavier\\r\\nuse. His sleep is very disrupted and he typically awakens around\\r\\n___ am and stays awake for several hours before falling back\\r\\nasleep. He also recalls snoring and has awoke at times with a \\r\\nthe\\r\\nfeeling that he has not been breathing well. Mr. ___ has also\\r\\nnoted that he feels a need to move his legs around when sleeping\\r\\nwhich he calls \"restless legs\". \\r\\n\\r\\nROS:  \\r\\n-POSITIVE: night sweats, unintentional weight loss, intermittent\\r\\nbilateral tinnitus, constipation since using chronic narcotics \\r\\nas\\r\\nan inpatient, + hematemesis after frequent analgesic use as an \\r\\nOP\\r\\n\\r\\n-NEGATIVE: The pt denied diplopia, dysarthria, dysphagia,\\r\\nlightheadedness, vertigo, or hearing difficulty. Denied\\r\\ndifficulties producing or comprehending speech. Denied focal\\r\\nweakness, numbness, paraesthesia. No bowel or bladder\\r\\nincontinence or retention. Denied difficulty with gait.  Denied\\r\\ncough, shortness of breath. Denied chest pain or tightness,\\r\\npalpitations. Denied nausea, vomiting, diarrhea, constipation or\\r\\nabdominal pain.No dysuria. Denied arthralgias or myalgias. \\r\\nDenied\\r\\nrash. \\r\\n \\r\\nPMH:  \\r\\n- Acute promyelocytic leukemia\\r\\n- Right knee surgery  \\r\\n- umbilical and ventral (non-mesh) hernia repairs ___, umbilical\\r\\nsuture removal for sinus tract ___\\r\\n- Bilateral retinal hemorrhage\\r\\n- HIV negative testing during this admission\\r\\n- multiple MVC\\'s, no hx of LOC  \\r\\n- headaches as described above\\r\\n- polysubstance abuse, now in remission \\r\\n\\r\\nOP Medications:  \\r\\n- PRN analgesics as described above\\r\\n\\r\\nIP Medications:\\r\\n- Tretinoin 40 mg PO BID \\r\\n- Meropenem 1000 mg IV Q8H \\r\\n- Vancomycin 1000 mg IV Q 12H  \\r\\n- Voriconazole 200 mg PO Q12H \\r\\n- Metronidazole (Flagyl) 500 mg IV Q8H \\r\\n- Acetaminophen 325-650 mg PO Q6H:PRN \\r\\n- Prochlorperazine 10 mg PO Q8H:PRN headache\\r\\n- Acetaminophen-Caff-Butalbital ___ TAB PO Q8H:PRN \\r\\n- Nicotine Patch 14 mg TD DAILY  \\r\\n- Allopurinol ___ mg PO DAILY  \\r\\n- Bisacodyl 10 mg PO DAILY:PRN  \\r\\n- Polyethylene Glycol 17 g PO DAILY \\r\\n- Caphosol 30 mL ORAL QID \\r\\n- Senna 1 TAB PO BID:PRN  \\r\\n- Cepacol (Menthol) 1 LOZ PO PRN  \\r\\n- DiphenhydrAMINE 25 mg PO/IV Q6H:PRN transfusion reaction  \\r\\n- Docusate Sodium 100 mg PO BID  \\r\\n\\r\\n- Lactulose 30 mL PO Q4H:PRN constipation  \\r\\n- Zolpidem Tartrate ___ mg PO HS:PRN  \\r\\n- Maalox/Diphenhydramine/Lidocaine ___ mL PO QID:PRN  \\r\\n \\r\\nAllergies:  NKDA\\r\\n\\r\\nSocial Hx: ___\\r\\n___ Hx:  \\r\\n-mother: headaches and emphysema\\r\\n-father:  heart disease\\r\\n-brother: migraines \\r\\n\\r\\nPhysical ___:  \\r\\nVitals: T: 99.8 P: 72 R: 16 BP: 100/60 SaO2: 99% RA \\r\\nGeneral: Awake, cooperative, NAD.  \\r\\nHEENT: NC/AT, no scleral icterus noted, MMM, no lesions noted in\\r\\noropharynx; clear tympanic membranes bilaterally \\r\\nNeck: Supple, no carotid bruits appreciated. No nuchal rigidity \\r\\n;\\r\\nneck and shoulder spasms L>R; + pain to palpation of the\\r\\ntemporalis muscle with reproducible pain in the L temple; + pain\\r\\nin L TMJ \\r\\nPulmonary: Lungs CTA bilaterally without R/R/W  \\r\\nCardiac: RRR, nl. S1S2, no M/R/G noted  \\r\\nAbdomen: soft, NT/ND, normoactive bowel sounds, no masses or\\r\\norganomegaly noted.  \\r\\nExtremities: No C/C/E bilaterally, 2+ radial, DP pulses\\r\\nbilaterally.  \\r\\nSkin: no rashes or lesions noted.  \\r\\n\\r\\nNeurologic:  \\r\\n-Mental Status: Alert, oriented x 3. Able to relate history\\r\\nwithout difficulty. Attentive, able to do serial 7\\'s without\\r\\ndifficulty. Language is fluent with intact repetition and\\r\\ncomprehension. Normal prosody. There were no paraphasic errors.\\r\\nPt. was able to name both high and low frequency objects. Able \\r\\nto\\r\\nread without difficulty. Speech was not dysarthric. Able to\\r\\nfollow both midline and appendicular commands. Pt. was able to\\r\\nregister 3 objects and recall ___ at 5 minutes ___ with\\r\\nprompting). The pt. had good knowledge of current events. There\\r\\nwas no evidence of apraxia or neglect.  \\r\\n\\r\\nCN  \\r\\nI: not tested  \\r\\nII,III: VFF to confrontation, pupils 4mm->2mm bilaterally, fundi\\r\\nnormal  \\r\\nIII,IV,V: EOMI, no ptosis. No nystagmus  \\r\\nV: sensation intact V1-V3 to LT  \\r\\nVII: Facial strength intact/symmetrical, symm forehead wrinkling \\r\\n\\r\\n\\r\\nVIII: hears finger rub bilaterally  \\r\\nIX,X: palate elevates symmetrically, uvula midline  \\r\\nXI: SCM/trapezeii ___ bilaterally  \\r\\nXII: tongue protrudes midline, no dysarthria  \\r\\n\\r\\nMotor: Normal bulk and tone; no asterixis or myoclonus. No\\r\\npronator drift.  \\r\\n   Delt Bi  Tri  WE FE Grip IO  \\r\\n   C5   C6  C7   C6 C7 C8/T1 T1  \\r\\nL  5    5   5    ___     5  \\r\\nR  5    5   5    ___     5  \\r\\n  \\r\\n  IP Quad ___ PF  \\r\\n  L2 L3   L4-S1 L4 L5  S1/S2  \\r\\nL  5  5     5    5 5    5    \\r\\nR  5  5     5    5 5    5  \\r\\n\\r\\nReflex: No clonus  \\r\\n  Bi Tri Bra Pat An Plantar  \\r\\n  C5 C7  C6  L4  S1 CST  \\r\\nL ___   2   ___ Flexor  \\r\\nR ___   2   ___ Flexor  \\r\\n\\r\\n-Sensory: No deficits to light touch, cold sensation, vibratory\\r\\nsense, proprioception throughout. No extinction to DSS.  \\r\\n\\r\\n-Coordination: No intention tremor, dysdiadochokinesia noted. No\\r\\ndysmetria on FNF or HKS bilaterally. Nl mirror testing \\r\\n\\r\\n-Gait: Good initiation. Narrow-based, normal stride and arm\\r\\nswing. Able to walk in tandem without difficulty. Romberg \\r\\nabsent.\\r\\n\\r\\nLaboratory Data:  \\r\\n135  98  14   \\r\\n------------/ 101   AGap=8\\r\\n4.1  29  0.6\\\\  \\r\\nCa: 8.9 Mg: 1.9 P: 4.2\\r\\nALT: 25 AP: 116 Tbili: 0.3 Alb:  AST: 21   \\r\\n\\r\\n 84 \\r\\n2.3 \\\\9.6/188 \\r\\n     26.7  \\r\\nN:4 Band:0 ___ M:38 E:0 Bas:0 Atyps: 10 Nrbc: 1 Other: 2  \\r\\nOther: Myelocytes Anisocy: 1+ Macrocy: 1+ Polychr: 1+ \\r\\n\\r\\nCSF ___:\\r\\nNEGATIVE FOR MALIGNANT CELLS.\\r\\nWBC 6 (Lymphs 56; Monocytes 44)\\r\\nRBC 166 \\r\\nProtien 26  \\r\\nGlucose 58\\r\\nGram stain: NO POLYMORPHONUCLEAR LEUKOCYTES SEEN.  NO\\r\\nMICROORGANISMS SEEN. \\r\\nCulture (bacterial, viral and fungal): NGTD \\r\\nHSV PCR: negative \\r\\n\\r\\nRadiologic Data:  \\r\\nNCHCT ___:  \\r\\nThere is no evidence of hemorrhage, edema, masses, mass effect,\\r\\nor \\r\\ninfarction. The ventricles and sulci are normal in caliber and\\r\\nconfiguration. There is no fracture. There is no evidence of\\r\\nintraocular hemorrhage. Of note, the left mastoid air cell is\\r\\nopacified. The paranasal sinuses and soft tissues are\\r\\nunremarkable. \\r\\n\\r\\nMRI Brain w/ and w/o contrast ___:\\r\\nThere is no evidence of mass, mass effect, or hemorrhagic \\r\\nchanges. Subtle areas of gyriform enhancement identified in the\\r\\noccipital lobes, possibly consistent with artifact after the\\r\\ninjection of gadolinium contrast, however, given the history of\\r\\nleukemia, infiltration cannot be completely ruled out. \\r\\n\\r\\nAssessment and Plan: The pt is a ___ year-old RH man with a\\r\\nhistory of intermittent headaches since his early ___, now\\r\\nwith chronic daily headaches for the last month. These occur in\\r\\nthe context of a recent diagnosis of acute promyelocytic \\r\\nleukemia\\r\\nwith treatment with chemotherapy (Atra), transient neutropenia,\\r\\nand neutropenic fevers. His headaches started prior to his\\r\\ndiagnosis of leukemia and are characterized by neck pain and\\r\\nradiation frontally. The pain occurs almost daily with\\r\\nintermittent periods of relief from pain after administration of\\r\\nanalgesics. The pain is worsened with lying down, Valsalva and\\r\\nhas awoke him from sleep. He has been using almost daily\\r\\nanalgesics for his pain for over a month and has also had\\r\\nseverely disrupted sleep. \\r\\n\\r\\nHis exam is remarkable for no nuchal rigidity. He does not have\\r\\npapilledema either but does have severe spasm of the neck and\\r\\nshoulders, worse on the L. He also has pain to palpation of the \\r\\nL\\r\\nTMJ with mild displacement of the jaw. His work-up to date has\\r\\nincluded an MRI of the brain with a question of gyriform\\r\\nenhancement which was felt to be likely secondary to artifact. \\r\\nHe\\r\\nhas also had an LP but the opening pressure was reportedly not\\r\\nrecorded. His CSF studies were not consistent with meningitis \\r\\nand\\r\\nhis cytology was negative. \\r\\n\\r\\nGiven this presentation, Mr. ___ headaches are most likely\\r\\nmultifactorial. They are likely due to muscle spasm headaches as\\r\\nwell as referred pain from TMJ and analgesic overuse headache.\\r\\nGiven his prior headache history, he may also have a component \\r\\nof\\r\\nmigraines as well. Once patients transform to chronic daily\\r\\nheadaches, it is often difficult to differentiate which \\r\\ncomponent\\r\\nis most prominent and therefore his headaches are likely\\r\\nmultifactorial. We would therefore suggest treatment with Valium\\r\\nas a muscle relaxant. We also counseled the patient on \\r\\nbehavioral\\r\\nmodifications including using firm pillows, heat applied to the\\r\\nneck and shoulder and muscle relaxation techniques. \\r\\nAdditionally,\\r\\navoidance of analgesics in order to detox from analgesic overuse\\r\\nis helpful. \\r\\n\\r\\nMore concerning, however is that the differential of his\\r\\nheadaches  also includes increased ICP headaches and meningitis.\\r\\nThis is suggested by the fact that his pain is worse with lying\\r\\ndown, Valsalva, awakening from sleep and neck pain. His exam \\r\\ndoes\\r\\nnot reveal papilledema or nuchal, however this is not always \\r\\nseen\\r\\nwith increased ICP and immunosuppression. An opening pressure\\r\\nwould have been helpful in assessing for increased ICP. \\r\\n\\r\\nGiven that there is no recorded opening pressure and possible\\r\\nenhancement on MRI, he should have further evaluation for\\r\\npossible CNS infiltration of his underlying malignancy,\\r\\nespecially for leptomeningeal disease. In regards to meningitis,\\r\\nthis would be most likely aseptic meningitis as he has no\\r\\nevidence of infection in his CSF profile and cultures and HSV \\r\\nare\\r\\nnegative to date. Thus the treatment for this is supportive. \\r\\n\\r\\nLastly, his history also reveals disrupted sleep with symptoms \\r\\nof\\r\\nrestless legs. He also describes periods of possible apnea.\\r\\nImpaired sleep frequently exacerbates headaches as well.\\r\\nTreatment for restless legs and future evaluation for sleep \\r\\napnea\\r\\nmay be indicated. \\r\\n\\r\\nRECOMMENDATIONS:\\r\\n-would start Valium 2mg PO QHS standing for neck spasm (this is\\r\\nalso effective for restless legs)\\r\\n-if no improvement over the next few days with Valium, may need\\r\\nto add a chronic therapy with Neurontin (also useful for \\r\\nrestless\\r\\nlegs)\\r\\n-repeat MRI brain with and without contrast (as there was a\\r\\nconcern for possible sublte enhancement on the prior MRI). This\\r\\nis likely artifact, however leptomeningeal disease is also on \\r\\nthe\\r\\ndifferential. \\r\\n-Should the repeat MRI show persistent enhancement, will need\\r\\nrepeat LP with opening pressure and cytology\\r\\n-avoid analgesics if possible in order to detox\\r\\n-will follow with you \\r\\n\\r\\nThis case was discussed with Dr. ___\\r\\nneurologist\\r\\n___, MD  \\r\\nNeurology PGY 3  \\r\\n\\r\\nAddendum by ___, MD on ___:\\r\\nI saw and examined Mr. ___ with Dr. ___ this\\r\\nafternoon.  I reviewed her note above and agree with the \\r\\nhistory,\\r\\nphysical exam findings and plan of care.  I would add the\\r\\nfollowing additional remarks:\\r\\n\\r\\nMr. ___ is a ___ year old man with a history of migraine\\r\\nheadaches for ___ years and recent diagnosis of acute\\r\\npromyelocytic leukemia s/p chemotherapy including tretinoin, who\\r\\nis seen regarding persistent daily headaches for the past 1.5\\r\\nmonths.  His headaches are likely multifactorial, including\\r\\ntension headaches (consistent with demonstrated muscle spasms),\\r\\nrebound headaches (given almost daily treatment with analgesic\\r\\npain medications), TMJ dysfunction noted on exam and poor sleep\\r\\n(perhaps worsened by anemia with APML resulting restless legs\\r\\nsymptoms).  In addition, tretinoin may also cause headaches in \\r\\nup\\r\\nto 85% of patients receiving it for treatment of APML.  Of\\r\\nconcern, of course, would be the possiblity of meningitis as the\\r\\ncause of his headaches, given his immunocompromised state. \\r\\nHowever, the persistent nature of these headaches, prior \\r\\nnegative\\r\\nCSF cultures and normal optic discs on examination today make\\r\\nthis less likely.  A carcinomatous mengitis is also possible,\\r\\nalthough prior CSF cytology was negative.  The possibility of\\r\\npseudotumor cerebri in the setting of tritenoin treatment is\\r\\npresent, although again his headaches have preceded treatment.  \\r\\n\\r\\nThus, agree with above plan to repeat brain MRI with contrast. \\r\\nIf this is normal, no further work up currently needed.  If,\\r\\nhowever, meningeal or cortical enhancement is noted, a repeat LP\\r\\nwith cytology and measurement of opening pressure is warranted.\\r\\n\\r\\nCurrent treatment of headaches with valium 2 mg at bedtime may\\r\\nassist both with muscle tension headaches and also his restless\\r\\nlegs symptoms.  Avoidance of analgesics may help avert an\\r\\nanalgesic rebound headache.  If these interventions are\\r\\ninsufficient to treat his headache, addition of a prophylactic\\r\\nheadache agent may be warranted.\\r\\n\\r\\nWe will continue to follow with you.  Thank you for involving us\\r\\nin Mr. ___ care.\\r\\nGeneral Surgery Consult:\\r\\nGeneral Surgery Re-Consult\\r\\n\\r\\nCC: umbilical site wound\\r\\n\\r\\nHPI: ___ M with AML who underwent umbilical hernia repair\\r\\n(without mesh) in ___, c/b by a draining sinus tract for which\\r\\nhe then underwent a local wound exploration.  Per patient, the\\r\\noutside hospital surgeon was not certain that he got all the\\r\\nsutures out.  The wound has been intermittently draining for the\\r\\npast 6 months.\\r\\n\\r\\nHe was admitted on ___ for pancytopenia and newly dx\\'d acute\\r\\npromyelocytic leukemia.  Surgery has been consulted twice for\\r\\nthis wound and deemed it to be a sinus tract, non-infected, not\\r\\nrequiring immediate drainage or exploration.  However, he has \\r\\nhad\\r\\npersistent low-grade fevers (100) and therefore has been on\\r\\nbroad-spectrum antibiotics for over two weeks now.  About 4 days\\r\\nago the patient reports developing a little outpocketing of the\\r\\nskin in the umbilicus, and that there was significant yellow\\r\\ndrainage overnight (but not today).  In light of his no longer\\r\\nbeing neutropenic, and the recent developments of his wound, a\\r\\nsurgical re-evaluation has been requested.\\r\\n\\r\\nPE: 99.2, 96, 90/60, 20, 97 on RA\\r\\nA&Ox3, NAD. WD WN.\\r\\nCTAB\\r\\nRRR\\r\\nsoft, NT, ND. transverse epigastric incision (former hernia\\r\\nrepair) well-healed but deep palpation elicits tenderness and a\\r\\nsuprafascial mobile mass c/w recurrent hernia.\\r\\numbilical site reveals an ___, with moisture along a \\r\\nvertical\\r\\ncrease.  There is a minimal rim of pink skin, not blanching. \\r\\nThere is a ~1cm size \"nubbin\" of skin along L lateral aspect of\\r\\numbilicus, which is not actively draining but mildly tender to\\r\\nsqueezing.\\r\\nWWP\\r\\n\\r\\nLabs ___:\\r\\n3.0 > 27.9 < 359 \\r\\n N:40 Band:0 ___ M:20 E:0 Bas:0 \\r\\n141  ___\\r\\n4.3  28  0.7  \\r\\nestGFR: >75 \\r\\nCa: 9.6 Mg: 2.0 P: 4.3\\r\\n\\r\\nWound Cx ___: NGTD\\r\\nWound Cx ___: MSSA\\r\\n\\r\\nA/P: ___ M with AML and peristent drainage from former \\r\\numbilical\\r\\nhernia repair site.  Currently does not appear infected, and\\r\\ndrainage is minimal.  Per oncology housestaff, this wound and\\r\\nlow-grade fevers are not interfering with his chemotherapy\\r\\nadministration.  Accordingly, would continue current management\\r\\nand plan to address this with a formal wound exploration on an\\r\\nelective basis as an outpatient after completion of his\\r\\nchemotherapy.\\r\\n-- will follow, ___ Surgery service, virtual pager ___.\\r\\n\\r\\nDiscussed with chief resident (Dr. ___ and staff (Dr.\\r\\n___\\r\\n\\r\\nDate: ___\\r\\nSigned by ___, MD on ___  Affiliation: \\r\\n___\\r\\n \\r\\nIntrathecal methotrexate given.  LP done under flouro by\\r\\ninterventional neuroradiology\\r\\n\\r\\nAdmission Consult:\\r\\nDate: ___\\r\\nSigned by ___, MD on ___  Affiliation: ___\\r\\nCosigned by ___, MD on ___\\r\\n \\r\\n___ Inpatient Admission Note:\\r\\n\\r\\nCC: ___\\r\\n\\r\\nHPI:  Mr. ___ is a ___ year old male with ___ weeks of\\r\\nworsening headache.  He reports that 4 weeks ago he was treated\\r\\nfor a tonsillitis with clindamycin and prednisone, which he\\r\\ncompleted 2 weeks ago.  He also presented with fevers when he \\r\\nhad\\r\\nhis tonsilitis.\\r\\n\\r\\nSince he completed the antibiotics, he has had a resolution in\\r\\nthe sore throat and fever but continues to have worsening\\r\\nheadache.  He has no prior history of headaches.  The headaches\\r\\nstart in the occiput and radiate to the forehead.  He reports\\r\\nintermittent blurred vision.\\r\\n\\r\\nHe reports one episode of mild epistaxis a few days ago.  He\\r\\ndenies gum bleeding, bloody, or melenic stool.  He has noticed\\r\\nincreased bruising lately.  He notices increasing fatigue and\\r\\ndyspnea on exertion.\\r\\n\\r\\nHe is not aware of having low blood counts when last seen for \\r\\nhis\\r\\ntonsillitis 4 weeks ago.\\r\\n\\r\\nHead CT done at outside hospital reportedly shows no bleed.\\r\\n\\r\\nMedications:\\r\\nAdvil Migraine\\r\\n\\r\\nPast Medical History:\\r\\nRight knee surgery\\r\\nUmbilical and abdominal hernia surgery\\r\\n\\r\\nFamily History:\\r\\nFather has heart disease\\r\\nNo history of anemias or hematologic malignancy in family.\\r\\n\\r\\nSocial History:\\r\\nLives in ___.\\r\\nHas a girlfriend of ___ years in monogamous relationship.\\r\\nDenies history if IVDA or cocaine abuse\\r\\nNo etoh use.\\r\\nSmokes 1ppd x ___ yrs\\r\\nUnemployed ___\\r\\nNo recent travel out of country\\r\\nHe has multiple tatoos on his body - he reports that he does \\r\\nthem\\r\\nhimself with sterile needles that he does not share.\\r\\n\\r\\nReview of Systems:\\r\\n\\r\\nDenies abdominal pain.  No change in bowel or bladder habits.\\r\\nNo cough.  He has noticed exertional chest pain.  Reports sweats\\r\\nand occasional chills.  No rashes.\\r\\n\\r\\nHR 110, BP 116/66, R20, 100 % RA\\r\\nGENERAL: alert, pleasant, in mild distress due to headache.\\r\\nHEENT: sclera anicteric, oropharynx and tongue pink and moist\\r\\nwithout lesions.\\r\\nLYMPH: without palpable cervical, axillary, periclavicular\\r\\nlymphadenopathy.\\r\\nLUNGS: clear to auscultation, scattered wheezes. no crackles or\\r\\nrhonchi.\\r\\nCARDIAC: RRR, without murmur, gallop or rub.\\r\\nABDOMEN: soft, non-tender, without hepatosplenomegaly or \\r\\npalpable\\r\\nmasses.\\r\\nEXTREMITIES: without edema, cyanosis or clubbing bilaterally.\\r\\nSKIN: without rashes, petechiae, or ecchymoses.  Multiple tatoos\\r\\non body.\\r\\nNEURO:Pupils equal, EOMI, strength full in all 4 extremities.\\r\\n\\r\\nLABS:\\r\\n\\r\\n   WBC  RBC    Hgb   Hct     MCV   MCH     MCHC    RDW   Plt Ct \\r\\n   1.8  1.19*  4.4*  12.4*2  104*   37.1*  35.7*   19.3*   9*\\r\\n\\r\\n Neuts Bands Lymphs Monos Eos Baso Atyps Metas Myelos NRBC Other \\r\\n\\r\\n    8*   2     67*    0    0    0    0    1*    1*     13* 21* \\r\\n\\r\\nPeripheral smear reveals: occasional blasts with abundant\\r\\ncytoplasm and pink/blue granules.  Rare Auer rods seen.  Red\\r\\ncells are macrocytic, normochromic, with nucleated RBCS, and\\r\\noccasional tear drops.  There are no schistocytes.\\r\\n\\r\\nINR 1.3, PTT 22.4, ___ 14.___.0\\r\\n\\r\\n Glucose UreaN Creat  Na   K    Cl   HCO3 AnGap \\r\\n   95     14    0.8   138  4.0  104   23    15 \\r\\n\\r\\n ALT AST LD(LDH)  AlkPhos  TotBili  \\r\\n ___      45      0.3 \\r\\n\\r\\nHaptoglobin 347\\r\\n\\r\\nAssessment and Plan:\\r\\n\\r\\nMr. ___ is a ___ year old male with ___ weeks of headache,\\r\\nfatigue and dyspnea on exertion.  Peripheral blood reveals\\r\\npancytopenia and examination of peripheral smear is suggestive \\r\\nof\\r\\nacute leukemia and probably acute promyelocytic leukemia.\\r\\n\\r\\nHe will be admitted to ___ service.\\r\\n\\r\\nHe will receive platelet transfusion STAT, followed by packed\\r\\nRBCs.  He will have a repeat head CT given worsening headache \\r\\nand\\r\\nblurred vision.\\r\\n\\r\\nWill check fibrinogen to rule out DIC.  If fibrinogen less than\\r\\n100, will give cryoprecipitate.\\r\\n\\r\\nWill give empiric ATRA this evening.\\r\\n\\r\\nBone marrow biopsy in the morning.\\r\\n\\r\\nThe patient was seen with attending physician ___.\\r\\nCase discussed with fellow, Dr. ___.\\r\\n\\r\\n___ MD\\r\\n___\\r\\nHematology/Oncology\\r\\n\\r\\nAddendum by ___, MD on ___:\\r\\npateint seen and examined. Agree with history and physical exam\\r\\nas described. In summary, ___ year old man who presents with\\r\\nseveral weeks of fatigue and headache, worsening today. Had a\\r\\nsore throat and fever several weeks ago treated with antibiotics\\r\\nand prednisone. Nosebleed several days ago. Found to be\\r\\npancytopenic with platelet count of 9K, hemoglobin 4.4, WBC 1.8.\\r\\nPeripheral blood smear reviewed. Blasts, granules, Auer fods,\\r\\nconcerning for APL. INR, PTT normal. Please transfuse Platelets\\r\\nstat followed by RBC. Repeat CT head to R/O bleed. Ophthamology\\r\\nto see for blurred vision. Keep platelets >50k, hct 20 tonight,\\r\\ncheck fibrinogen and give cryoprecipitate to keep fibrinogen >\\r\\n100. Given concern for APL, start ATRA 45mg/m2 now\\r\\n.\\r\\n\\r\\n \\r\\nMedications on Admission:\\r\\nIbuprofen prn migraine\\r\\n \\r\\nDischarge Medications:\\r\\n1. Tretinoin (Chemotherapy) 10 mg Capsule Sig: Four (4) Capsule \\r\\nPO BID (2 times a day).  \\r\\n2. Butalbital-Acetaminophen-Caff 50-325-40 mg Tablet Sig: One \\r\\n(1) Tablet PO Q8H (every 8 hours) as needed.\\r\\nDisp:*30 Tablet(s)* Refills:*0*\\r\\n\\r\\n \\r\\nDischarge Disposition:\\r\\nHome\\r\\n \\r\\nDischarge Diagnosis:\\r\\nPrimary Diagnoses\\r\\n- Acute Promyelocytic Leukemia\\r\\n- Retinal Hemorrhage\\r\\n- Febrile Neutropenia\\r\\n- Tension Headache\\r\\n\\r\\n \\r\\nDischarge Condition:\\r\\nGood. Patient ambulating, taking good PO, and as his mental and \\r\\nphysical baseline.\\r\\n\\r\\n \\r\\nDischarge Instructions:\\r\\nYou were admitted to hospital with fevers, sore throat and were \\r\\nfound to have acute promyelocytic leukemia. You were treated \\r\\nwith oral, IV chemotherapy over the course of 39 days. You also \\r\\nunderwent a lumbar puncture that showed no evidence of leukemia \\r\\nin your cerebrel spinal fluid.\\r\\n.\\r\\nYou were seen by Neurology that evaluated your headaches. The \\r\\nteam suggests that you seek follow-up with a Neurologist for \\r\\nthese symptoms if they persist.\\r\\n.\\r\\nPlease continue to take all of you medications as listed below. \\r\\nA number of changes have been made to your medication regimen. \\r\\n1) Atra (Tretinoin) 10mg x 4 capsules (40mg) by mouth, twice \\r\\ndaily\\r\\n2) Fioricet 1 pill as needed for Tension Headaches\\r\\n.\\r\\nPlease keep all of your appointments.\\r\\n.\\r\\nPlease return to the hospital if you experience fevers, chills, \\r\\nworsening headaches, visual changes, worsening neck pain, \\r\\nworsening drainage or redness around you belly-button. \\r\\n \\r\\nFollowup Instructions:\\r\\n___\\r\\n<|eot_id|><|start_header_id|>assistant<|end_header_id|>\\n\\n'"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "output[0].prompt"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "ebf46991",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "True"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "prompts[np.argmax(token_len)] == output[0].prompt"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "23767378",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "LLM",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.12"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
